Bio Saga Headlines

Bio Saga

Friday, June 10, 2011

Persistent Buys Agilent's Software Marketing and Development Business

Persistent Systems Ltd (PSL) has signed an agreement to acquire Agilent Technologies' software marketing and development business unit based in Grenoble, France.
The acquisition is expected to be final by August 1, after which the unit will be called Persistent Systems, France.

Dr Anand Deshpande, Chairman and Managing Director, PSL said the acquisition will contribute to Persistent's thrust in the life sciences and healthcare markets and also give it a presence in Europe.
Around 30 domain experts from Agilent will come on board once the transaction is completed and more may be added, he said.

The Agilent business is now focused on supplying data acquisition and control software for scientific instruments to the life sciences, environmental, energy, applied research and other markets. Currently, PSL's Life Sciences business contributes 10-12 per cent to its topline and was worth $20 million in FY 2011.

The team here includes over 40 domain experts and more than 500 software professionals working on services supporting laboratory instrumentation, bioinformatics and chemical informatics projects for leading companies.

Centre of excellence

To leverage the life sciences business, Persistent plans to set up a Life Sciences Centre of Excellence in Grenoble to expand into the European market. While bringing in new solutions and services to these, the centre will also provide it a platform to leverage its corporate technology position in areas such as cloud, analytics, mobility and collaboration.

No comments:

Life Science and Informatics

What is this?
is this a new industry?
or a old wine in a new bottle?

Well Life Sciences and Informatics can be anything form computational biology, all omes and omics, core bioinformatics to curation and literature mining, database creation, in the area of biology, chemistry , bio-chem space.

There are number of companies in India and bangalore is the forefront as a major bio-cluster with 20 to 30 companies in this sphere.

now how good are these companies doing?
how good are they in terms of the international markets and how profitable is their business?
what do they do?
their clients?

These are some interesting things that could be discussed in this blog page...

Tag It